explore -WSS

explore

author：leisure time 2025-10-01 21:48:32 - browse：8939

Perrigo Opill press photo – pharma coverage from STAT — Opill, the first over-the-counter birth control pill, is on its way to U.S. stores. Perrigo via AP

WASHINGTON — The first over-the-counter birth control pill will be available in U.S. stores later this month, allowing American women and teens to purchase contraceptive medication as easily as they buy aspirin.

Manufacturer Perrigo said Monday it has begun shipping the medication, Opill, to major retailers and pharmacies. A one-month supply will cost about $20 and a three-month supply will cost around $50, according to the company’s suggested retail price. It will also be sold online.

The launch has been closely watched since last July, when the Food and Drug Administration said the once-a-day Opill could be sold without a prescription. Ireland-based Perrigo noted there will be no age restrictions on sales, similar to other over-the-counter medications.

Opill is an older class of contraceptive, sometimes called minipills, that contain a single synthetic hormone, progestin, and generally carry fewer side effects than more popular combination estrogen and progestin pills.

Newsletters

Sign up for Morning Rounds

Understand how science, health policy, and medicine shape the world every day

Please enter a valid email address. Privacy Policy

The launch gives U.S. women another birth control option amid the legal and political battles over reproductive health, including the reversal of Roe v. Wade, which has upended abortion access across the U.S. Opill’s approval is unrelated to the ongoing court battles over the abortion pill mifepristone. And anti-abortion groups have generally emphasized that they do not oppose contraceptives to prevent pregnancies.

Birth control pills are available without a prescription across much of South America, Asia, and Africa.

The drug’s approval came despite some concerns by FDA scientists about the company’s results, including whether women with certain medical conditions would understand that they shouldn’t take the drug.

Dr. Verda Hicks, president of the American College of Obstetricians and Gynecologists, in a statement, said studies have shown that patients, including adolescents, can effectively screen themselves to use the pills.

— Matthew Perrone

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： EHR maker NextGen Healthcare to pay $31M to resolve fraud claims

focus

WSS

Detailed data confirm benefits, risks of Eli Lilly's Alzheimer's drug

Bird flu surveillance in wastewater gets boost from consortium

Citing H5N1 threat, CDC urges peak flu monitoring this summer

In early work, researchers turn to CRISPR to treat Alzheimer's

Sanofi seeks simpler, safer CRISPR sickle cell cure

As digital health tech proliferates, a new institute aims to cut through hype

leisure time

explore

Sign up for Morning Rounds

focus

After affirmative action ruling, medical educators look to 'holistic review'

Cosmetics set for new safety regulation. Why the industry is on board

ChatGPT in medicine: STAT answers readers' burning questions

Digital health: a case of mistaken identity

Cancer drug shortages should be causing more outrage

EHR maker NextGen Healthcare to pay $31M to resolve fraud claims

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Questions and answers about ramping up H5N1 bird flu vaccine

How to save PrEP access — and even expand it

Investigation reveals sickle cell patients pressured into sterilizations

leisure time

Bird flu surveillance in wastewater gets boost from consortium

Rescued Australian man who was adrift 3 months in Pacific with dog 'grateful' to be alive

Detailed data confirm benefits, risks of Eli Lilly's Alzheimer's drug

Questions and answers about ramping up H5N1 bird flu vaccine

In early work, researchers turn to CRISPR to treat Alzheimer's

Citing H5N1 threat, CDC urges peak flu monitoring this summer

focus

focus

leisure time

hotspot